Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Weini Wang
Targeting Ovarian Cancer Stem Cells by Dual Inhibition of the Long Noncoding RNA HOTAIR and Lysine Methyltransferase EZH2
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells
Molecular Cell Biology Xingyue Zong, Weini Wang, Ali Ozes, Fang Fang, George E. Sandusky and Kenneth P. Nephew DOI: 10.1158/0008-5472.CAN-20-0458 Published October 2020 This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below. Abstract The majority of women diagnosed with epithelial ovarian cancer eventually develop recurrence, which rapidly evolves into chemoresistant disease.
EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells
Molecular Cell Biology Xingyue Zong, Weini Wang, Ali Ozes, Fang Fang, George E. Sandusky and Kenneth P. Nephew DOI: 10.1158/0008-5472.CAN-20-0458 Abstract The majority of women diagnosed with epithelial ovarian cancer eventually develop recurrence, which rapidly evolves into chemoresistant disease. Persistence of ovarian cancer stem cells (OCSC) at the end of therapy may be responsible for emergence of resistant tumors.
EZH2-mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells
Research Article Xingyue Zong, Weini Wang, Ali Ozes, Fang Fang, George E. Sandusky and Kenneth P. Nephew DOI: 10.1158/0008-5472.CAN-20-0458 Abstract The majority of women diagnosed with epithelial ovarian cancer (OC) eventually develop recurrence which rapidly evolves into chemoresistant disease. Persistence of ovarian cancer stem cells (OCSC) at the end of therapy may be responsible for emergence of resistant tumors.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Weini
Contact Weini, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack